Skip to menu Skip to content Skip to footer

2021

Journal Article

Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes

Jones, Michael P., Walter, Susanna, Talley, Nicholas J., Walker, Marjorie M., Holtmann, Gerald J., Shah, Ayesha, D'Amato, Mauro, Agréus, Lars and Andreasson, Anna (2021). Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes. European Journal of Gastroenterology and Hepatology, 33 (S1), e740-e745. doi: 10.1097/MEG.0000000000002236

Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes

2021

Journal Article

Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders

Jones, Michael P., Shah, Ayesha, Walker, Marjorie M., Koloski, Natasha A., Holtmann, Gerald and Talley, Nicholas J. (2021). Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders. United European Gastroenterology Journal, 9 (9), 1074-1080. doi: 10.1002/ueg2.12164

Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders

2021

Journal Article

Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue

Hoedt, Emily C., Shanahan, Erin R., Keely, Simon, Shah, Ayesha, Burns, Grace L., Holtmann, Gerald J., Talley, Nicholas J. and Morrison, Mark (2021). Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue. Microbiology Resource Announcements, 10 (39) e00758, e0075821. doi: 10.1128/MRA.00758-21

Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue

2021

Journal Article

Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis

Johnson, Kevin M., Fischer, Ryan T., Holtmann, Gerald J., Shah, Ayesha, Alrabadi, Leina and Lewindon, Peter (2021). Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis. Hepatology, 74 (3), 1716-1717. doi: 10.1002/hep.31764

Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis

2021

Journal Article

Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia

Shah, Ayesha, Gurusamy, Saravana Ruban, Hansen, Teressa, Callaghan, Gavin, Talley, Nicholas J., Koloski, Natasha, Walker, Marjorie M., Jones, Michael P., Morrison, Mark and Holtmann, Gerald J. (2021). Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia. Digestive Diseases and Sciences, 67 (6), 2299-2309. doi: 10.1007/s10620-021-07149-1

Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia

2021

Journal Article

Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseases

Jones, Michael P., Shah, Ayesha, Ben-Jacob, Ronen, Talley, Nicholas J., Hansen, Teressa, Walker, Marjorie M., Gray, Marcus, Koloski, Natasha A. and Holtmann, Gerald (2021). Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseases. Neurogastroenterology and Motility, 33 (8) e14091, e14091. doi: 10.1111/nmo.14091

Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseases

2021

Journal Article

Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double-blind, placebo-controlled parallel-group trial

Talley, N. J., Walker, M. M., Jones, M., Keely, S., Koloski, N., Cameron, R., Fairlie, T., Burns, G., Shah, A., Hansen, T., Harris, G. and Holtmann, G. (2021). Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double-blind, placebo-controlled parallel-group trial. Alimentary Pharmacology and Therapeutics, 53 (12), 1332-1333. doi: 10.1111/apt.16396

Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double-blind, placebo-controlled parallel-group trial

2021

Journal Article

Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis

Gurusamy, Saravana Ruban, Shah, Ayesha, Talley, Nicholas J., Koloski, Natasha, Jones, Michael P., Walker, Marjorie M., Morrison, Mark and Holtmann, Gerald (2021). Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis. The American Journal of Gastroenterology, 116 (5), 935-942. doi: 10.14309/ajg.0000000000001197

Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis

2021

Journal Article

From trash to gold: Gastrointestinal microbiome research in patients with functional gastrointestinal disorders

Holtmann, Gerald, Shah, Ayesha and Morrison, Mark (2021). From trash to gold: Gastrointestinal microbiome research in patients with functional gastrointestinal disorders. Journal of Investigative Medicine, 69 (4), 793-795. doi: 10.1136/jim-2021-001903

From trash to gold: Gastrointestinal microbiome research in patients with functional gastrointestinal disorders

2021

Journal Article

Is a fundamental design change for gastrointestinal endoscopes required?

Holtmann, Gerald J., Huelsen, Alexander, Shah, Ayesha, Hourigan, Luke F. and Morrison, Mark (2021). Is a fundamental design change for gastrointestinal endoscopes required?. Journal of Clinical Gastroenterology, 55 (1), 21-24. doi: 10.1097/MCG.0000000000001430

Is a fundamental design change for gastrointestinal endoscopes required?

2021

Journal Article

Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: a systematic review and meta-analysis

Gandhi, Arjun, Shah, Ayesha, Jones, Michael P., Koloski, Natasha, Talley, Nicholas J., Morrison, Mark and Holtmann, Gerald (2021). Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: a systematic review and meta-analysis. Gut Microbes, 13 (1) 1933313, 1-16. doi: 10.1080/19490976.2021.1933313

Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: a systematic review and meta-analysis

2021

Journal Article

Patient-reported gastrointestinal symptoms and the association with quality of life following kidney transplantation

Chan, Samuel, Cao, Christopher, Pascoe, Elaine M., Johnson, David W., Shah, Ayesha, Holtmann, Gerald A., Campbell, Scott B., Francis, Ross S., Isbel, Nicole M. and Hawley, Carmel M. (2021). Patient-reported gastrointestinal symptoms and the association with quality of life following kidney transplantation. Kidney International Reports, 6 (1), 138-145. doi: 10.1016/j.ekir.2020.10.013

Patient-reported gastrointestinal symptoms and the association with quality of life following kidney transplantation

2020

Journal Article

Basics of meta-analysis

Shah, Ayesha, Jones, Michael P. and Holtmann, Gerald J. (2020). Basics of meta-analysis. Indian Journal of Gastroenterology, 39 (5), 503-513. doi: 10.1007/s12664-020-01107-x

Basics of meta-analysis

2020

Journal Article

A role for primary care pharmacists in the management of inflammatory bowel disease? Lessons from chronic disease: A systematic review

Prasad, Sharmila S, Duncanson, Kerith, Keely, Simon, Talley, Nicholas J, Kairuz, Therése, Holtmann, Gerald J, Shah, Ayesha and Walker, Marjorie M (2020). A role for primary care pharmacists in the management of inflammatory bowel disease? Lessons from chronic disease: A systematic review. Pharmacy, 8 (4) 204, 204-13. doi: 10.3390/pharmacy8040204

A role for primary care pharmacists in the management of inflammatory bowel disease? Lessons from chronic disease: A systematic review

2020

Journal Article

Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity

Talley, Nicholas J., Holtmann, Gerald J., Jones, Michael, Koloski, Natasha A., Walker, Marjorie M., Burns, Grace, Potter, Michael D. E., Shah, Ayesha and Keely, Simon (2020). Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity. Gut, 69 (9), 1-3. doi: 10.1136/gutjnl-2019-318664

Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity

2020

Journal Article

Low ambient temperatures are associated with more rapid spread of COVID-19 in the early phase of the endemic

Holtmann, Mathias, Jones, Mike, Shah, Ayesha and Holtmann, Gerald (2020). Low ambient temperatures are associated with more rapid spread of COVID-19 in the early phase of the endemic. Environmental Research, 186 109625, 1-2. doi: 10.1016/j.envres.2020.109625

Low ambient temperatures are associated with more rapid spread of COVID-19 in the early phase of the endemic

2020

Journal Article

Targeting the gut microbiome as a treatment for primary sclerosing cholangitis: a conceptional framework

Shah, Ayesha, Macdonald, Graeme A., Morrison, Mark and Holtmann, Gerald (2020). Targeting the gut microbiome as a treatment for primary sclerosing cholangitis: a conceptional framework. The American Journal of Gastroenterology, 115 (6), 814-822. doi: 10.14309/ajg.0000000000000604

Targeting the gut microbiome as a treatment for primary sclerosing cholangitis: a conceptional framework

2020

Journal Article

Correction to: An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy (Indian Journal of Gastroenterology, (2019), 38, 3, (268-272), 10.1007/s12664-019-00966-3)

Kutyla, Marguerite J., Shah, Ayesha, Elson, Jerome, Meeusen, Vera, O’Connor, Sam, Hourigan, Luke F. and Holtmann, Gerald J. (2020). Correction to: An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy (Indian Journal of Gastroenterology, (2019), 38, 3, (268-272), 10.1007/s12664-019-00966-3). Indian Journal of Gastroenterology, 38 (6), 557-557. doi: 10.1007/s12664-019-01010-0

Correction to: An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy (Indian Journal of Gastroenterology, (2019), 38, 3, (268-272), 10.1007/s12664-019-00966-3)

2020

Journal Article

Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies

Shah, Ayesha, Talley, Nicholas J., Jones, Michael, Kendall, Bradley, Koloski, Natasha, Walker, Marjorie, Morrison, Mark and Holtmann, Gerald J. (2020). Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. American Journal of Gastroenterology, 115 (2), 190-201. doi: 10.14309/ajg.0000000000000504

Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies

2020

Journal Article

“It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic

Holtmann, Gerald, Quigley, Eamonn M., Shah, Ayesha, Camilleri, Michael, Tan, Victoria P.Y., Gwee, Kok Ann, Sugano, Kentaro, Sollano, Jose D., Fock, Kwong M., Ghoshal, Uday C., Chen, Minhu, Dignass, Axel and Cohen, Henry (2020). “It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic. Journal of Gastroenterology and Hepatology, 35 (7), 1117-1123. doi: 10.1111/jgh.15133

“It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic